STAT1 min read
STAT+: Up And Down The Ladder: The Latest Comings And Goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About RSV Vax Link To GSB, A Pfizer Donation, And More
In today's Pharmalittle roundup, we're reading about RSV vaccines' link to Guillain-Barré syndrome, a Pfizer donation that caught lawmakers' eyes, and more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About White House Eyeing PBMs, Pfizer CEO’s Frustrations, And More
In today's Pharmalittle roundup, we're reading about the White House eyeing PBMs, the Pfizer CEO's frustrations, and more.
STAT1 min read
Chikungunya Vaccine Approved For Select Groups By CDC Advisory Panel
Adult travelers and researchers to regions outside the U.S. where the mosquito-borne virus is endemic may receive the vaccine, the group said Wednesday.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About The FTC Vs. PBMs, FDA Adcomm Voting And More
The U.S. FDA plans to increase the number of inspections at Indian drug manufacturers in 2024 amid growing concerns over quality issues
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Congress Punts PBM Reform, Another Obesity Drug And More
BioMarin Pharmaceutical received a subpoena from the U.S. Department of Justice seeking information about the sponsored testing programs.
STAT2 min read
STAT+: FDA Protocols Originally Intended To Be Extra Conservative Are Now Heralded As Evidence Of Mifepristone’s Risk
Decisions made by the FDA more than 20 years ago have come under heightened scrutiny thanks to a lawsuit calling for increased restrictions around the abortion pill mifepristone.
STAT2 min read
STAT+: MD Anderson Tried — And Failed — To Resolve Research Credit Dispute Between Two Scientists, New Documents Show
Whose idea was it? New documents reveal deep divide in a dispute involving Padmanee Sharma, one of MD Anderson’s most prominent scientists, and a junior researcher.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About State Moves On Drug Pricing, An Asthma Med For Kids And More
Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription drug pricing. It's a big victory for the pharmaceutical industry:
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Pharma Job Slowdown, Diet Drugs Boosting GDP, And More
The widespread use of new weight loss drugs in the U.S. could boost gross domestic product by 1% through a boost in workplace efficiency.
STAT1 min readSecurity
STAT+: UnitedHealth Cyberattack Impedes Pharmacies’ And Hospitals’ Ability To Process Insurance Claims
Hospitals and pharmacies are stuck in an insurance processing logjam after a cyberattack on UnitedHealth's Change Healthcare.
STAT1 min read
STAT+: Annovis Bio Delivers Candor On Its Parkinson’s Study, Even If It Doesn’t Inspire Much Confidence
Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire much confidence.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About India-made Versions Of Wegovy, An RSV Vaccine Scramble, And More
Indian drugmakers aiming to grab a slice of the weight loss treatment sales pie are developing their own versions of Novo Nordisk's Wegovy.
STAT1 min read
STAT+: DarioHealth Acquires Twill, Hoping It’s A Shortcut To Profitability
DarioHealth, with apps for managing chronic diseases, will acquire mental health app maker Twill, hoping to attract large customers and become profitable.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A CEO Change At AbbVie, A Long-acting HIV Drug, And More
AbbVie announced that CEO Richard Gonzalez, who has managed its ascent since being spun off from Abbott Laboratories in 2013, will step down in July.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Weight Loss Drugs, A Cell Therapy For Melanoma, And More
China has more obese people than anywhere else in the world, and they are increasingly turning to weight loss drugs, fueling a gray market.
STAT1 min read
STAT+: Leading MD Anderson Oncologist Disputes Junior Scientist’s Claims In Lawsuit Over Research Credit
Padmanee Sharma, one of MD Anderson's most influential scientists, is disputing a lawsuit filed by a junior researcher in a contentious case over research credit.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Kids Taking Wegovy, Telehealth For Abortion Pills, And More
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's Wegovy weight loss drug last year.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A FTC Probe Into GPOs, A Frostbite Drug, And More
The U.S. FTC is launching a probe into the extent to which group purchasing organizations and wholesalers may contribute to shortages of key drugs at hospitals.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Slow Uptake Of An Alzheimer’s Drug, An Opioid Lawsuit, And More
Seven months after the FDA fully approved a Biogen treatment for Alzheimer’s disease, only about 2,000 patients are taking Leqembi nationwide.
STAT1 min read
STAT+: Digital Tools Helped Lower Blood Pressure In Marginalized Patient Groups
A new analysis suggests that there ought to be more investment in novel hypertension programs for patients experiencing health disparities.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Tossed PhRMA Lawsuit, Secrecy Clauses, And More
A U.S. district judge granted a Biden administration request to dismiss a PhRMA lawsuit challenging Medicare’s new drug price negotiation program.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Moderna’s RSV Vaccine, Aurobindo Problems, And More
In this morning's Pharmalittle roundup, we're reading about Moderna's RSV vaccine, Aurobindo problems, and more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A U.S. Vaccine Panel, An Abortion Pill, And Much More
A medical journal has retracted two studies claiming to show the harms of the abortion pill mifepristone.
STAT1 min read
Opinion: Moving From Crisis Response To Crisis Prevention In U.S. Mental Health Systems
Despite widespread promises of reform after the murder of George Floyd in 2020, in 2023, police killed at least 1,246 people — the most in more than a decade. This police violence is intertwined with a parallel public policy disaster: America’s abysm
STAT2 min read
STAT+: Pharmalittle: We Are Reading About Catalent Concerns, A Congressional Hearing, And More
The European Medicines Agency will investigate any risks to the availability of medicines processed at Catalent plants that will be sold to Novo Nordisk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Lawsuit Against J&J, Express Scripts Dealings, And More
Johnson & Johnson faces a consequential new class action lawsuit for allegedly overpaying its pharmacy benefit manager for its employees’ medicines.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Novo Buying Catalent, Amgen’s Obesity Drug, And More
The investment arm of Novo Nordisk’s parent foundation is buying Catalent, a contract development and manufacturing company with more than 50 sites globally.
…Or Discover Something New